imatinib mesylate
SpainDrugs containing this active substance
-
It is used to treat various types of cancer in adults and children/adolescents, including chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), and other blood disorders.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 119,500 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat various types of cancer in adults and children/adolescents, including chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), and other blood disorders such as myelodysplastic/myeloproliferative syndromes (MDS/MPN) or hypereosinophilic syndrome (HES).
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 478,00 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat certain types of cancer in adults and children, such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), as well as other blood disorders such as myelodysplastic/myeloproliferative syndromes and hypereosinophilic syndrome.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 119,50 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat several types of cancer and blood disorders, such as chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 478 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat certain types of cancer in adults and children, such as chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), among other blood diseases.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 119,50 mg Manufacturer: Laboratorios Normon S.A.
-
It is used to treat certain types of cancer in adults and children, such as chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, gastrointestinal stromal tumors (GIST), among other blood and tissue diseases.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 478,00 mg Manufacturer: Laboratorios Normon S.A.
-
It is used to treat certain types of cancer in adults and children, such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), among other blood diseases.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 119,5 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat various types of cancer in adults and children, such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), among other blood diseases.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 478 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat adults and children with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). In adults, it is also prescribed for myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, and gastrointestinal stromal tumors (GIST), as well as for dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 119,5 mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat adults and children with certain types of cancer, such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), and other blood disorders such as myelodysplastic/myeloproliferative syndromes or hypereosinophilic syndrome.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 478 mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat adults and children with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). In adults, it is also prescribed for myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia (CEL), gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 119,469 mg mg Manufacturer: Teva B.V.
-
It is used to treat various types of cancer in adults and children, including chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), as well as certain myelodysplastic/myeloproliferative syndromes and hypereosinophilic syndrome.
Form: tablets, film-coated
Active substance Dosage imatinib mesylate 477,877 mg mg Manufacturer: Teva B.V.